# Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction

> **NCT00006070** · PHASE2 · COMPLETED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 86 (—)

## Conditions studied

- Healthy
- Inflammation

## Interventions

- **DRUG:** etanercept (Enbrel)

## Key facts

- **NCT ID:** NCT00006070
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 86 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006070, "Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00006070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*